Cancer-associated retinopathy in a child with Langerhans cell histiocytosis.
Hayashi
Masako
M
Department of Ophthalmology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan. ramktcap@apricot.ocn.ne.jp.
Hatsukawa
Yoshikazu
Y
Department of Ophthalmology, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
Yasui
Masahiko
M
Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
Yanagihara
Itaru
I
Department of Developmental Infectious Diseases, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
Ohguro
Hiroshi
H
Department of Ophthalmology and Visual Science, Sapporo Medical University School of Medicine, Sapporo, Japan.
Fujikado
Takashi
T
Department of Ophthalmology, Osaka University Medical School, Osaka, Japan.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012164:Retinal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D016559:Tacrolimus / Q000627:therapeutic use; D014792:Visual Acuity / Q000502:physiology; D014794:Visual Fields / Q000502:physiology
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D016559:Tacrolimus